New Vernon Capital Holdings Ii LLC Protagonist Therapeutics, Inc Transaction History
New Vernon Capital Holdings Ii LLC
- $170 Million
- Q4 2024
A detailed history of New Vernon Capital Holdings Ii LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, New Vernon Capital Holdings Ii LLC holds 3,061 shares of PTGX stock, worth $117,817. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,061Holding current value
$117,817% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding PTGX
# of Institutions
254Shares Held
58.9MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$228 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$222 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$212 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$162 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$128 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $1.89B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...